Effects of alendronate on the Notch1-RBP-Jκ signaling pathway in the osteogenic differentiation and mineralization of vascular smooth muscle cells

Molecular Medicine Reports

Volumn 8, Issue 1, 2013, Pages 89-94

  Zhou, Shaoqiong ^a   Fang, Xin ^a   Xin, Huaping ^a   Guan, Siming ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Alendronate; Calcification; Notch1 RBP J signaling pathway; Vascular smooth muscle cells

Indexed keywords

ALENDRONIC ACID; ALKALINE PHOSPHATASE; CALCIUM; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN; NOTCH1 RECEPTOR;

ANIMAL CELL; ARTICLE; BLOOD VESSEL CALCIFICATION; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; MALE; MINERALIZATION; NONHUMAN; OSTEOBLAST; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ALENDRONATE; ALKALINE PHOSPHATASE; ANIMALS; CALCIUM; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OSTEOGENESIS; RATS; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION; VASCULAR CALCIFICATION;

RATTUS;

EID: 84878936163     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1489     Document Type: Article

References (38)

1. United Nations: World Population Ageing. New York, USA, 2009.
2. World Health Report. World Health Organization, Geneva, 2002.
3. Santos LL, Cavalcanti TB and Bandeira FA: Vascular effects of bisphosphonates - a systematic review. Clin Med Insights Endocrinol Diabetes 5: 47-54, 2012.
4. Lampropoulos CE, Papaioannou I and D'Cruz DP: Osteoporosis - a risk factor for cardiovascular disease? Nat Rev Rheumatol 8: 587-598, 2012.
5. Perrini S, Natalicchio A, Laviola L, et al: Abnormalities of insulin-like growth factor-I signaling and impaired cell proliferation in osteoblasts from subjects with osteoporosis. Endocrinology 149: 1302-1313, 2008. (Pubitemid 351397940)
6. Mithal A: Osteoporosis in Asia: a call to action. Osteoporos Int 23: S739-S740, 2012.
7. Yesil Y, Ulger Z, Halil M, et al: Coexistence of osteoporosis (OP) and coronary artery disease (CAD) in the elderly: It is not just a by chance event. Arch Gerontol Geriatr 54: 473-476, 2012.
8. Rhee EJ, Lee WY, Kim SY, et al: Relationship of serum osteoprotegerin levels with coronary artery disease severity, left ventricular hypertrophy and C-reactive protein. Clin Sci (Lond) 108: 237-243, 2005.
9. Vattikuti R and Towler DA: Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab 286: E686-E696, 2004. (Pubitemid 38506938)
10. Giachelli CM: Vascular calcification mechanisms. J Am Soc Nephrol 15: 2959-2964, 2004.
11. Hofbauer LC, Brueck CC, Shanahan CM, Schoppet M and Dobnig H: Vascular calcification and osteoporosis - from clinical observation towards molecular understanding. Osteoporos Int 18: 251-259, 2007. (Pubitemid 46233170)
12. Price PA, Faus SA and Williamson MK: Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler Thromb Vasc Biol 21: 817-824, 2001. (Pubitemid 32448773)
13. Skolnick AH, Osranek M, Formica P and Kronzon I: Osteoporosis treatment and progression of aortic stenosis. Am J Cardiol 104: 122-124, 2009.
14. Ylitalo R, Kalliovalkama J, Wu XM, et al: Accumulation of bisphosphonates in human artery and their effects on human and rat arterial function in vitro. Pharmacol Toxicol 83: 125-131, 1998. (Pubitemid 28432379)
15. London GM: Bone-vascular cross-talk. J Nephrol 25: 619-625, 2012.
16. Boanini E, Torricelli P, Gazzano M, Fini M and Bigi A: The effect of alendronate doped calcium phosphates on bone cells activity. Bone 51: 944-952, 2012.
17. Keam SJ and Plosker GL: Prevention and treatment of osteoporosis in postmenopausal women. Dis Manag Health Outcome 12: 19-37, 2004.
18. Iwamoto J, Takeda T, Sato Y and Uzawa M: Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosis. Clin Rheumatol 23: 383-389, 2004. (Pubitemid 39386432)
19. Manderfield LJ, High FA, Engleka KA, et al: Notch activation of Jagged1 contributes to the assembly of the arterial wall. Circulation 125: 314-323, 2012.
20. Kurpinski K, Lam H, Chu JL, et al: Transforming growth factor-beta and notch signaling mediate stem cell differentiation into smooth muscle cells. Stem Cells 28: 734-742, 2010.
21. Morimoto M, Liu ZY, Cheng HT, Winters N, Bader D and Kopan R: Canonical Notch signaling in the developing lung is required for determination of arterial smooth muscle cells and selection of Clara versus ciliated cell fate. J Cell Sci 123: 213-224, 2010.
22. Shimizu T, Tanaka T, Iso T, et al: Notch signaling induces osteogenic differentiation and mineralization of vascular smooth muscle cells: role of Msx2 gene induction via Notch-RBP-Jk signaling. Arterioscler Thromb Vasc Biol 29: 1104-1111, 2009.
23. Morrow D, Guha S, Sweeney C, et al: Notch and vascular smooth muscle cell phenotype. Circ Res 103: 1370-1382, 2008.
24. Iyemere VP, Proudfoot D, Weissberg PL and Shanahan CM: Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification. J Intern Med 260: 192-210, 2006. (Pubitemid 44253633)
25. Sage AP, Tintut Y and Demer LL: Regulatory mechanisms in vascular calcification. Nat Rev Cardiol 7: 528-536, 2010.
26. Wang M, Wu L, Wang L and Xin X: Down-regulation of Notch1 by gamma-secretase inhibition contributes to cell growth inhibition and apoptosis in ovarian cancer cells A2780. Biochem Biophys Res Commun 393: 144-149, 2010.
27. Price PA, June HH, Buckley JR and Williamson MK: Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol 21: 1610-1616, 2001. (Pubitemid 34215580)
28. Xin H, Xin F, Zhou S and Guan S: The Wnt5a/Ror2 pathway is associated with determination of the differentiation fate of bone marrow mesenchymal stem cells in vascular calcification. Int J Mol Med 31: 583-588, 2013.
29. Zuo C, Huang Y, Bajis R, et al: Osteoblastogenesis regulation signals in bone remodeling. Osteoporos Int 23: 1653-1663, 2012.
30. Zanotti S and Canalis E: Notch signaling and bone. IBMS BoneKEy 8: 318-327, 2011.
31. Doi H, Iso T, Shiba Y, et al: Notch signaling regulates the differentiation of bone marrow-derived cells into smooth muscle-like cells during arterial lesion formation. Biochem Biophys Res Commun 381: 654-659, 2009.
32. Engin FZ, Yao ZQ, Yang T, et al: Dimorphic effects of Notch signaling in bone homeostasis. Nat Med 14: 299-305, 2008. (Pubitemid 351347909)
33. Maeda K, Kobayashi Y, Udagawa N, et al: Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis. Nat Med 18: 405-412, 2012.
34. Al-Aly Z: Arterial calcification: a tumor necrosis factor-alpha mediated vascular Wnt-opothy. Transl Res 151: 233-239, 2008.
35. Nie B, Zhou S, Fang X, Li W, Wang B and Guan S: Implication of receptor activator of NF-kappaB ligand in Wnt/beta-catenin pathway promoting osteoblast-like cell differentiation. J Huazhong Univ Sci Technolog Med Sci 32: 818-822, 2012.
36. Iso T, Hamamori Y and Kedes L: Notch signaling in vascular development. Arterioscler Thromb Vasc Biol 23: 543-553, 2003. (Pubitemid 36438065)
37. Morrow D, Scheller A, Birney YA, et al: Notch-mediated CBF-1/RBP-J{kappa}-dependent regulation of human vascular smooth muscle cell phenotype in vitro. Am J Physiol Cell Physiol 289: C1188-C1196, 2005. (Pubitemid 41456835)
38. Shimizu T, Tanaka T, Iso T and Kurabayashi M: Notch signaling directly targets Msx2: possible role of notch signaling in osteogenic conversion of vascular smooth muscle cells and vascular calcification. Circulation 118: S368, 2008.